BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2013
View Archived Issues
Ono obtains rights to opicapone for Parkinson's disease in Japan
Read More
Using microRNAs to differentiate between low- and high-risk pancreatic neoplasms
Read More
Roche develops interleukin-2 variant for cancer immunotherapy
Read More
Galapagos developing novel candidate drug for triple-negative breast cancer
Read More
Researchers discover novel genetic risk factor for Behcet's disease
Read More
Serum levels of beta-2-microglobulin predict mortality in patients with diabetes
Read More
New ways to protect from Parkinson's disease
Read More
SAR-154782 experiments reveal tumor growth pathways linked to NAMPT
Read More
Merck Serono obtains marketing rights to Cetrotide
Read More
Aurigene and Endo Pharmaceuticals achieve important milestones
Read More
FDA approves beta-blocker-free, fixed-combination therapy for glaucoma
Read More
Hexyon/Hexacima 6-in-1 pediatric vaccine approved in Europe
Read More
Indian scientists disclose novel CETP inhibitors
Read More
ViroPharma reports data from phase II study of VP-20621
Read More
GlaxoSmithKline presents new RORgamma modulators
Read More
MethylGene discovers novel VEGFR-2 inhibitors
Read More
Lundbeck describes new PDE10A inhibitors
Read More
Ono Pharmaceutical identifies novel S1P2 receptor antagonists
Read More
Aduro and Johns Hopkins University to evaluate Aduro vaccine technologies with anti-PD-1
Read More
ARCA biopharma and Medtronic to collaborate on atrial fibrillation burden substudy
Read More
Aastrom Biosciences commences treatment in phase IIb study of ixmyelocel-T
Read More
Synta begins treatment in confirmatory GALAXY-2 study of ganetespib
Read More
New agreement covers phase II HCV study of daclatasvir and MK-5172 combination
Read More
Senesco completes cohort 2 in phase Ib/IIa study of SNS01-T
Read More
Sareum and SRI International sign codevelopment agreement for TYK2 inhibitors
Read More
Interim phase II results for Mesoblast's mesenchymal precursor cells for intervertebral disc repair
Read More